Skip to main content

Health & Medicine

Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly

Source: Reuters
Insilico Medicine secures $2.75 billion drug collaboration with Eli Lilly

Insilico Medicine has secured a $2.75 billion drug development collaboration with Eli Lilly, reflecting the pharmaceutical industry's growing investment in AI-powered research and development. The partnership demonstrates major pharma companies' confidence in AI-driven drug discovery tools and automated laboratory systems to accelerate the development pipeline. This deal aligns with broader industry trends and regulatory support from the FDA for adopting artificial intelligence in drug development.

Read Full Article at Reuters

Related Articles